Research Coverage

Delta-Fly Pharma

Code: 4598Last Update:
Research Reports
Download Research Report

Using its proprietary module technology, pharmaceutical company Delta-Fly conducts R&D into new anticancer agents. Module technology is a unique drug discovery method that takes the active ingredients (modules) of anticancer agents from existing drugs whose patents have expired or whose development was halted due to side effects and combines them to create new drugs with an improved balance of clinical efficacy and safety.

Our Policy

We interview management for hours, asking exhaustive questions to uncover the essence of the business.

We pinpoint strengths and weaknesses, and discuss strategy. Our aim is to make deep knowledge about the company readily available, saving investors time and enabling dialogue.

Our Research

We start our coverage with a substantial core report. We then continuously update this report to reflect earnings, newsflow, and any material developments. We interview the management quarterly to help you stay on top of the story.

Our report is an authoritative Owner’s Manual of the company—a vital piece in the investor’s toolbox.

For Investors

If you find our efforts valuable, please tell companies you want them to join our growing client list.